Perturbation of the mitosis/apoptosis balance: A fundamental mechanism in toxicology

Fundamental and Applied Toxicology

Volumn 38, Issue 2, 1997, Pages 107-115

  Roberts, Ruth A ^a   Nebert, Dan W ^e   Hickman, John A ^c   Richburg, John H ^d   Goldsworthy, Thomas L ^b  

^a ASTRAZENECA   (United Kingdom)

^b CIIT CENTERS FOR HEALTH RESEARCH   (United States)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d BROWN UNIVERSITY   (United States)

^e UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; DIOXIN; FLUOROURACIL; PHTHALIC ACID 2 ETHYLHEXYL MONOESTER;

ANIMAL EXPERIMENT; APOPTOSIS; CARCINOGENESIS; COLON; GERM CELL; LIVER CELL; MITOSIS; MOUSE; NONHUMAN; REVIEW; SMALL INTESTINE;

ANIMALIA;

EID: 85033543738     PISSN: 02720590     EISSN: None     Source Type: Journal    
DOI: 10.1006/faat.1997.2331     Document Type: Review

References (44)

1. Aldridge T. C., Tugwood J. D., Green S. Identification and characterization of DNA elements implicated in the regulation of CYP4A1 transcription. Biochem. J. 306:1995;473-479.
2. Ames B. N., Gold L. S. Too many rodent carcinogens: Mitogenesis increases mutagenesis. Science. 249:1990;970-971.
3. Ashby J., Brady A., Elcombe C. R., Elliot B. M., Ishmael J., Odum J., Tugwood J. D., Kettle S., Purchase I. F. H. Mechanistically-based human hazard assessment of peroxisome-proliferator-induced hepatocarcinogenesis. Hum. Exp. Toxicol. 13:1994;S1-S117.
4. Barrass N. C., Price R. J., Lake B. G., Orton T. C. Comparison of the acute and chronic mitogenic effects of the peroxisome proliferators methylclofenapate and clofibric acid in rat liver. Carcinogenesis. 14:1993;1451-1456.
5. Bayly A. C., Roberts R. A., Dive C. Suppression of liver cell apoptosis in vitro by the non-genotoxic hepatocarcinogen and peroxisome proliferator, nafenopin. J. Cell Biol. 125:1994;197-203.
6. Bentley P., Calder I., Elcombe E., Grasso P., Stringer D., Wiegand H. J. Hepatic peroxisome proliferation in rodents and its significance to humans. Food Chem. Toxicol. 31:1993;857-907.
7. Billig H., Furuta I., Rivier C., Tapanainen J., Parvinen M., Hsueh A. J. W. Apoptosis in testis germ cells: Developmental changes in gonadotropin dependence and localisation to selective tubule stages. Endocrinology. 136:1995;5-12.
8. Bursch B., Lauer B., Timmerman-Trosiener I., Barthel G., Schuppler J., Schulte-Hermann R. Controlled death (apoptosis) of normal and preneoplastic cells in rat liver following withdrawal of tumor promoters. Carcinogenesis. 5:1984;453-458.
9. Cunningham M. L. Role of increased DNA replication in the carcinogenic risk of nonmutagenic chemical carcinogens. Mutat. Res. 365:1996;59-69.
10. De Rooij D., Lok D. Regulation of the density of spermatogonia in the seminiferous epithelium of the Chinese hamster, II. Anat. Rec. 217:1987;131-136.
11. Dive C., Hickman J. A. Drug target interactions: Only the first step in the commitment to programmed cell death. Br. J. Cancer. 6:1991;192-196.
12. Dive C., Evans C. A., Whetton A. D. Induction of apoptosis - New targets for cancer chemotherapy. Semin. Cancer Biol. 3:1992;417-427.
13. Eacho P. I., Lanier P. L., Brodhecker C. A. Hepatocellular DNA synthesis in rats given peroxisome proliferating agents: Comparison of WY-14,643 to clofibric acid, nafenopin and LY171883. Carcinogenesis. 12:1991;1557-1561.
14. Elcombe C. R., Mitchell A. Peroxisome proliferation due to di(2-ethyl) phthalate: Species differences and possible mechanisms. Environ. Health Perspect. 70:1986;211-219.
15. Fausto N., Webber E. M. Control of liver growth. Crit. Rev. Eukaryotic Gene Expression. 3:1993;117-135.
16. Gill J. H., Roberts R. A., Dive C. The peroxisome proliferator nafenopin can suppress rat hepatocyte apoptosis induced by TGFß1, DNA damage or Fas. Carcinogenesis. 1997.
17. Goldsworthy T. L., Conolly R. B., Fransson-Steen R. Apoptosis and cancer risk assesement. Mutat. Res. 365:1996a;71-90.
18. Goldsworthy T. L., Fransson-Steen R., Maronpot R. R. Importance of and approaches to quantification of hepatocyte apoptosis. Toxicol. Pathol. 24:1996b;24-35.
19. Grasl-Kraupp B., Huber W., Timmermann-Trosiener I., Schulte-Hermann R. Peroxisomal enzyme induction uncoupled from enhanced DNA synthesis in putative preneoplastic foci of rats treated with a single dose of the peroxisome proliferator, nafenopin. Carcinogenesis. 14:1993;2435-2437.
20. Issemann I., Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature. 347:1990;645-650.
21. Issemann I., Prince R. A., Tugwood J. D., Green S. The peroxisome proliferator-activated receptor: Retinoid X receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs. J. Mol. Endocrinol. 11:1993;37-47.
22. James N. H., Roberts R. A. Species differences in response to peroxisome proliferators correlate in vitro with induction of DNA synthesis rather than with suppression of apoptosis. Carcinogenesis. 17:1996;1623-1632.
23. Kyprinaou N., Isaacs J. Expression of TGFß1 in the rat ventral prostate during castration induced programmed cell death. Mol. Endocrinol. 3:1989;1515-1522.
24. Lee J., Richburg J., Younkin S. C., Boekelheide K. The fas system is a key regulator of germ cell apoptosis in the testis. Endocrinology. 1997.
25. Lee S. S.-T., Pineau T., Drago J., Lee E. J., Owens J. O., Kroetz D. L., Fernandez-Salguero P. M., Westphal H., Gonzalez F. J. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleitrophic effects of peroxisome proliferators. Mol. Cell. Biol. 15:1995;3012-3022.
26. Merritt A. J., Potten C. S., Kemp C. J., Hickman J. A., Balmain A., Lane D. P., Hall P. A. The role of p53 in spontaneous and radiation-induced apoptosis in the GI tract of normal and p53-deficient mice. Cancer Res. 54:1993;614.
27. Merritt A. J., Potten C. S., Watson A. J. M., Loh D. Y., Nakayama L., Nakayama K., Hickman J. A. Differential expression of bcl-2 in intestinal epithelia. Correlation with the attenuation of apoptosis in colonic crypts and the incidence of colonic neoplasia. J. Cell Sci. 108:1995;2261.
28. Moody D. E., Reddy J. K., Lake B. G., Popp J. A., Reese D. H. Peroxisome proliferation and non-genotoxic carcinogenesis: Commentary on a symposium. Fundam. Appl. Toxicol. 6:1991;233-248.
29. Nebert D. W., Puga A., Vasiliou V. Role of the Ah receptor and the dioxin-inducible (Ah) gene battery in toxicity, cancer and signal transduction. Ann. N.Y. Acad. Sci. 685:1993;624-640.
30. Oberhammer F. A., Roberts R. A. Apoptosis: A widespread process involved in liver adaptation and carcinogenesis. The Liver: Biology and Pathobiology. 1994;Raven Press, New York. p. 1547-1556.
31. Potten C. S. The significance of spontaneous and induced apoptosis in the GI tract. Cancer Metastasis Rev. 11:1992;179.
32. Pritchard D. M., Watson A. J., Potten C. S., Jackman A. L., Hickman J. A. Inhibition by uridine but not thymidine of p53-dependent intestinal apoptosis initiated by 5-fluorouracil: Evidence for the involvement of RNA perturbation. Proc. Natl. Acad. Sci. USA. 94:1997;1795.
33. Puga A., Nebert D. W., Carrier F. Dioxin induces expression of c-fos and c-jun protooncogenes and a large increase in transcription factor AP1. DNA Cell Biol. 11:1992;269-281.
34. Reed J. C. Regulation of apoptosis by bcl2 family proteins and its role in cancer and chemoresistance. Curr. Opin. Oncol. 7:1995;541.
35. Richardson F. C., Dyroff M. C., Boucheron J. A., Swenberg J. A. Differential repair ofO. Carcinogenesis. 6:1985;625-629.
36. Richburg J., Boekelheide K. MEHP rapidly alters both Sertoli cell vimentin filaments and germ cell apoptosis in young rat testes. Toxicol. Appl. Pharmacol. 137:1996;42-50.
37. Roberts R. A. Non-genotoxic hepatocarcinogenesis: Suppression of apoptosis by peroxisome proliferators. Reddy J. K., Suga T., Mannaerts G. P., Lazarow P. B., Subramani S. Peroxisomes: Biology and Role in Toxicology and Disease. 1996;588-602 N.Y. Acad. Sci. New York.
38. Roberts R. A., Soames A. R., Gill J. H., James N. H., Wheeldon E. B. Non-genotoxic hepatocarcinogens stimulate DNA synthesis and their withdrawal induces apoptosis, but in different discrete hepatocyte populations. Carcinogenesis. 16:1995;1693-1698.
39. R. A. Roberts, N. H. James, N. Woodyatt, N. Macdonald, J. Tugwood, 1997, Suppression of apoptosis by PPARα
40. Schulte-Hermann R. Adaptive liver growth induced by xenobiotic compounds: Its nature and mechanism. Arch. Toxicol. Suppl. 2:1979;113-124.
41. Strange J., Roberts R. A. Reduced expression of mature TGFß1 correlates with the suppression of rat hepatocyte apoptosis by the peroxisome proliferator, nafenopin. Mutat. Res. 372:1996;107-113.
42. Tugwood J. D., Issemann I., Anderson R. G., Bundell K. R., McPheat W. L., Green S. The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene. EMBO J. 11:1992;433-439.
43. Tugwood J. D., Aldridge T. C., Lambe K. L., Macdonald N., Woodyatt N. J. PPARs: Structures and function. Reddy J. K., Suga T., Mannaerts G. P., Lazarow P. B., Subramani S. Peroxisomes: Biology and Role in Toxicology and Disease. 1996;252-265 N. Y. Acad. Sci. New York.
44. Yen P. M., Chin W. W. Molecular mechanisms of dominant negative activity by nuclear hormone receptors. Mol. Endocrinol. 8:1994;1450-1454.